Page last updated: 2024-08-23

bucindolol and enoximone

bucindolol has been researched along with enoximone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clark, AL; Cleland, JG; Coletta, AP; Ingle, L; Lalukota, K	1

Reviews

1 review(s) available for bucindolol and enoximone

Article	Year
Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD. European journal of heart failure, 2004, Volume: 6, Issue:7 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine; Cardiotonic Agents; Cardiovascular Agents; Crataegus; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Homozygote; Humans; Oxygen Consumption; Plant Extracts; Propanolamines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-1; Societies, Medical; Stroke Volume; Survival Analysis; Treatment Failure; Treatment Outcome; United States	2004

Article

Year

Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD.

European journal of heart failure, 2004, Volume: 6, Issue:7

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine; Cardiotonic Agents; Cardiovascular Agents; Crataegus; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Homozygote; Humans; Oxygen Consumption; Plant Extracts; Propanolamines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-1; Societies, Medical; Stroke Volume; Survival Analysis; Treatment Failure; Treatment Outcome; United States

2004